ATAI Life Sciences NV
ATAI3.770USD
+0.360+10.56%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
906.45M시가총액
손실P/E TTM
자세한 내용은 ATAI Life Sciences NV 회사
Atai Beckley NV, formerly ATAI Life Sciences NV, is a clinical-stage biopharmaceutical company. The Company focused on developing treatments for mental health disorders. The Company's pipeline includes psychedelic and non-psychedelic compounds targeting depression, anxiety, and other unmet needs in psychiatry.
ATAI Life Sciences NV 정보
종목 코드 ATAI
회사 이름Atai Beckley NV
상장일Jun 18, 2021
CEORao (Srinivas G)
직원 수54
유형Ordinary Share
회계 연도 종료Jun 18
주소Prof. J.H.Bavincklaan 7
도시AMSTELVEEN
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Netherlands
우편 번호1183 AT
전화31207932536
웹사이트https://www.atai.com/
종목 코드 ATAI
상장일Jun 18, 2021
CEORao (Srinivas G)
ATAI Life Sciences NV의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Glenn Frank Short, Ph.D.
Dr. Glenn Frank Short, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
42.33K
+19339.00%
Ms. Andrea Heslin Smiley
Ms. Andrea Heslin Smiley
Independent Supervisory Director
Independent Supervisory Director
4.67K
--
Mr. Christian Angermayer
Mr. Christian Angermayer
Chairman of the Supervisory Board
Chairman of the Supervisory Board
--
--
Ms. Sabrina Martucci Johnson
Ms. Sabrina Martucci Johnson
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Amir Kalali
Dr. Amir Kalali
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Srinivas Rao, M.D., Ph.D.
Dr. Srinivas Rao, M.D., Ph.D.
Chief Executive Officer, Co-Founder, Interim Managing Director
Chief Executive Officer, Co-Founder, Interim Managing Director
--
--
Ms. Anne Johnson
Ms. Anne Johnson
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Gerd G. Kochendoerfer
Dr. Gerd G. Kochendoerfer
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Kevin James Craig, M.D.
Dr. Kevin James Craig, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Scott N. Braunstein, M.D.
Dr. Scott N. Braunstein, M.D.
Independent Supervisory Director
Independent Supervisory Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Glenn Frank Short, Ph.D.
Dr. Glenn Frank Short, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
42.33K
+19339.00%
Ms. Andrea Heslin Smiley
Ms. Andrea Heslin Smiley
Independent Supervisory Director
Independent Supervisory Director
4.67K
--
Mr. Christian Angermayer
Mr. Christian Angermayer
Chairman of the Supervisory Board
Chairman of the Supervisory Board
--
--
Ms. Sabrina Martucci Johnson
Ms. Sabrina Martucci Johnson
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Amir Kalali
Dr. Amir Kalali
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Srinivas Rao, M.D., Ph.D.
Dr. Srinivas Rao, M.D., Ph.D.
Chief Executive Officer, Co-Founder, Interim Managing Director
Chief Executive Officer, Co-Founder, Interim Managing Director
--
--
수익 분석
기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Sat, Feb 7
마지막 업데이트: Sat, Feb 7
주주
주주 유형
주주
주주
비율
Apeiron Investment Group Ltd
15.20%
Feilding-Mellen (Cosmo)
2.11%
Adage Capital Management, L.P.
1.50%
Brand (Florian Olaf)
1.39%
Morgan Stanley Investment Management Inc. (US)
0.89%
기타
78.91%
주주
주주
비율
Apeiron Investment Group Ltd
15.20%
Feilding-Mellen (Cosmo)
2.11%
Adage Capital Management, L.P.
1.50%
Brand (Florian Olaf)
1.39%
Morgan Stanley Investment Management Inc. (US)
0.89%
기타
78.91%
주주 유형
주주
비율
Family Office
15.22%
Hedge Fund
4.58%
Investment Advisor
3.86%
Individual Investor
3.69%
Investment Advisor/Hedge Fund
1.88%
Research Firm
1.23%
Private Equity
0.39%
Endowment Fund
0.20%
Venture Capital
0.05%
기타
68.90%
기관 주식 보유
마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
218
45.07M
10.88%
+16.45K
2025Q3
249
45.57M
19.55%
+12.66M
2025Q2
225
29.96M
14.58%
+6.94M
2025Q1
223
23.03M
12.83%
-2.41M
2024Q4
236
15.60M
13.86%
+2.09M
2024Q3
236
13.53M
16.71%
-545.79K
2024Q2
246
14.10M
16.43%
-259.20K
2024Q1
244
14.41M
17.26%
-14.24M
2023Q4
251
15.93M
17.75%
-1.57M
2023Q3
259
17.69M
19.30%
-562.50K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Apeiron Investment Group Ltd
55.21M
15.2%
+14.20K
+0.03%
Oct 20, 2025
Feilding-Mellen (Cosmo)
7.70M
2.12%
+7.70M
--
Nov 05, 2025
Adage Capital Management, L.P.
5.43M
1.5%
--
--
Sep 30, 2025
Brand (Florian Olaf)
5.04M
1.39%
-250.00K
-4.73%
Sep 15, 2025
Morgan Stanley Investment Management Inc. (US)
3.23M
0.89%
+1.39M
+75.10%
Sep 30, 2025
Citadel Advisors LLC
2.58M
0.71%
+1.40M
+118.39%
Sep 30, 2025
Ally Bridge Group NY LLC
2.29M
0.63%
+2.29M
--
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
2.18M
0.6%
+2.11M
+2973.34%
Dec 31, 2025
Candriam Luxembourg S.A.
1.72M
0.47%
--
--
Nov 30, 2025
ARK Investment Management LLC
2.02M
0.56%
+457.76K
+29.31%
Sep 30, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
AdvisorShares Psychedelics ETF
17.55%
ARK Genomic Revolution ETF
1.6%
Invesco NASDAQ Future Gen 200 ETF
0.69%
Even Herd Long Short ETF
0.14%
Avantis US Small Cap Equity ETF
0.08%
First Trust IPOX Europe Equity Opportunities ETF
0.06%
SPDR S&P International Small Cap ETF
0.05%
Fidelity Nasdaq Composite Index ETF
0%
ProShares Ultra Nasdaq Biotechnology
0%
Avantis US Equity ETF
0%
더 보기
AdvisorShares Psychedelics ETF
비율17.55%
ARK Genomic Revolution ETF
비율1.6%
Invesco NASDAQ Future Gen 200 ETF
비율0.69%
Even Herd Long Short ETF
비율0.14%
Avantis US Small Cap Equity ETF
비율0.08%
First Trust IPOX Europe Equity Opportunities ETF
비율0.06%
SPDR S&P International Small Cap ETF
비율0.05%
Fidelity Nasdaq Composite Index ETF
비율0%
ProShares Ultra Nasdaq Biotechnology
비율0%
Avantis US Equity ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
